Latest News view all news

11/06/2023

New FDA approval for BMS in melanoma

09/19/2023

Pfizer Inc. is pleased to announce that the FDA has approved TALZENNA®

08/30/2023

KRAS G12C inhibitor evaluated in NSCLC patients with untreated CNS metastases

08/25/2023

FDA-approval in Multiple Myeloma

Upcoming Events view all events

 November 2023 
SMTWTFS
   1234
567891011
1213141516
1718
19202122232425
2627282930  

None at this time.

Corporate Members view all sponsors